গাইড লিঙ্ক ক্যুইজ · মাঝারি স্তর
এআই ফুসফুসের নডিউল সনাক্তকরণ কুইজ
NLST এবং USPSTF থেকে ফুসফুসের স্ক্রীনিং প্রমাণ পরীক্ষা করে, ফুসফুস-RADS এবং Fleischner নির্দেশিকাগুলির মধ্যে পার্থক্য এবং কীভাবে নোডুল ডিটেক্টর পরিমাপ করা হয়।
প্রশ্ন 1 এর 8
In the National Lung Screening Trial, low-dose CT was compared with which alternative?
প্রতিটি প্রশ্নের পূর্বরূপ দেখুন8 প্রশ্ন
আপনি কুইজ নেওয়ার সাথে সাথে উত্তর এবং ব্যাখ্যাগুলি উপস্থিত হয়।
- In the National Lung Screening Trial, low-dose CT was compared with which alternative?
- No screening at all
- MRI
- Sputum testing
- Chest X-ray
- Which age range did the 2021 USPSTF recommendation set for annual lung cancer screening?
- 40 to 70
- 50 to 80
- 55 to 74
- 60 to 90
- A 9 mm nodule turns up by chance on a CT done for abdominal pain. According to the guide, which guidelines usually govern its follow-up?
- Fleischner Society guidelines
- Lung-RADS
- KDIGO criteria
- NEWS2
- What makes Sybil, from MIT and Massachusetts General Hospital, different from a standard nodule detector?
- It performs biopsies robotically
- It only works on chest X-rays
- It estimates future lung cancer risk from a single low-dose CT, even with no suspicious nodule visible
- It replaces the need for radiologists to read scans
- Why are nodule detectors often evaluated with FROC curves?
- They show sensitivity against the average false positives per scan, which fits scans that can hold several nodules
- They measure radiation dose
- They rank vendors by price
- They report how long each scan takes
- What does a nodule's volume doubling time help clinicians judge?
- The patient's lung capacity
- How fast the nodule is growing, with faster growth suggesting cancer
- Which scanner produced the image
- Whether contrast dye was used
- Why does the guide say it is a misconception that AI diagnoses lung cancer?
- AI cannot see ground-glass nodules
- AI only works on patients who smoke
- The FDA bans AI in lung imaging
- AI flags nodules and estimates risk, but only tissue sampling confirms cancer
- A detector that did well at one hospital performs worse at another. Which explanation does the guide give?
- The second hospital's patients have larger lungs
- Nodules look different in different countries
- Differences in slice thickness, reconstruction kernel, dose and scanner vendor change what the model sees
- The model forgets its training over time